Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.
2 things he said, it will take 8 weeks to get the data as data is king and then move quickly after that and also he says its potential for mcap is off the page given the certain circumstances so i wouldn't be too excited about major news in the next 2 weeks. Everyone wants to hear if Southampton went well but as he says he will wait until he has all the data from all the sites and go from there.
Hold hold hold and your patience will be rewarded.
Pre 2pm slumo made by MMs to shake a few sellers! They will need to shake a lot harder!
Only JK i trust is JK ROWLING. All the rest are spoofers.
Whats the mezt resistance after 90p?
3 scenarios
Share pice stays as is....
Share price drops by 7p( as calculated earlier)
Or news flows and it rises massively next week.
Personally i can take a hit of 7p over short term as i am not selling but I wouldn't be waiting until the 14th to see if the share price drops a small bit and risk missing out on big news..
Sorry if that classifies as ramping.
Pilgrim,
Is this the list of hospitals that was mentioned on sky news and bbc i think on Friday that had this board hopping on Friday? I see oxford doctors on sky news too, but no names of the drugs they are trialing, so is that SNG? 4 hospitals would be around 50 patients each 25 real and 25 placebo. That could be very easily achieved.
Is the Leicester application form for sng trials too? Sorry for asking you but you seem to be up to date on which hospitals they are using!
Hi Green,
No I don't think so,but i will let tge experts on here say fot definite. it looks like a race is on here to find something that might cure Covid-19. No mention of SNG which is a shame, but SNG is not a cure just a treatment
The trial is being coordinated by researchers at the University of Oxford, led by Peter Horby, Professor of Emerging Infectious Diseases and Global Health in the Nuffield Department of Medicine, and Martin Landray, Professor of Medicine and Epidemiology at the Nuffield Department of Population Health.
To ensure that the healthcare system research resource is directed to benefit the national effort, the National Institute for Health Research (NIHR) has put in place a national process to prioritise COVID-19 research. The RECOVERY trial is one of those prioritised.
The study has received £2.1 million from UK Research and Innovation (UKRI) and the Department of Health and Social Care, through the NIHR. It is part of a wider £20 million rapid research response investment by the government to support looking at ways to tackle the coronavirus outbreak.
The move further bolsters the ‘research’ phase in the government’s science-led coronavirus action plan.
It follows decisive action by the UK’s medicines regulator to fast-track clinical trials for potential coronavirus treatments, meaning NHS patients could have faster access if medicines are proven to be effective.
The Medicines and Healthcare products Regulatory Agency (MHRA) has been working hard to put in place procedures to support manufacturers and researchers developing these treatments and approve clinical trial applications in days, rather than weeks. Its experience as a world-renowned regulator means these rapid approvals are based on the latest scientific advice and do not compromise the government’s top priority of maintaining patient safety.
Peter Horby, Professor of Emerging Infectious Diseases and Global Health in the Nuffield Department of Medicine, University of Oxford, said:
The RECOVERY trial will provide much-needed evidence on the best care for patients with COVID-19. The more patients that are enrolled, the sooner we will know how best to treat this disease.
We are very grateful to those patients who are participating and to the hospital and research staff who are helping us to find the best treatments.
Notes to editor
See full details on the trial
Patients with COVID-19 are being offered the opportunity to participate in this trial. If they agree, they will be randomly allocated to standard of care alone, or standard of care plus 1 of 3 additional treatments
The trial began on 19 March. It was set up in record time: first protocol to first patient in 9 days and 13 days to reach 500 patients. Within the first 2 weeks, nearly 1,000 patients have been enrolled
The data will be analysed on a rolling basis so that any beneficial treatments can be identified as soon as possible. The faster that patients are recruited, the sooner the reliable results
The other 2 key national trials are PRINCIPLE and REMAP-CAP
Find out more about the NIHR’s national process to prioritise COVID-19 research. See details on the process and the new single point of entry for prio
Press release
World's largest trial of potential coronavirus treatments rolled out across the UK
The largest randomised clinical trial of potential coronavirus (COVID-19) treatments is underway as part of the race to find a treatment.
Published 3 April 2020
From:
Department of Health and Social Care
placeholder
The world’s largest randomised clinical trial of potential coronavirus treatments is well underway in the UK as part of the race to find a treatment.
A number of promising treatments are being tested and, if the science supports it, will be given to NHS patients as quickly as possible.
Definitive results on whether the treatments are safe and effective are expected within months and, if positive, they could potentially benefit hundreds of thousands of people worldwide.
Almost 1,000 patients from 132 different hospitals have been already recruited in just 15 days and thousands more are expected to join the Randomised Evaluation of COVID-19 Therapy (RECOVERY) trial in the coming weeks, making it the largest randomised controlled trial of potential COVID-19 treatments in the world.
Health and Social Care Secretary Matt Han**** said:
The coronavirus outbreak is the biggest public health emergency in a generation and we are doing everything we can to fight it on all fronts through our evidence-based action plan.
The UK is leading the way on research in the race to find treatments and we have now launched the largest trial in the world, pooling resources with our world-leading life science sector.
As one of three major trials funded by the government, this marks a major milestone in our battle against coronavirus and offers renewed hope that together we can beat this.
The public still has a crucial role to play by staying at home so we can protect the NHS and save lives.
The trial is testing a number of medicines recommended by an expert panel advising the Chief Medical Officer for England. They include:
Lopinavir-Ritonavir, commonly used to treat HIV
Dexamethasone, a type of steroid use in a range of conditions to reduce inflammation
Hydroxychloroquine, a treatment for malaria
The trial is being conducted in over 130 NHS hospitals across the UK. Adult patients who have been admitted to hospital with COVID-19 are being invited to take part. The trial is specially designed so that as further medicines are identified, these can be added to the study within days.
Chief Medical Officer Professor Chris Whitty said:
The UK has world-leading life sciences and research sectors and, because of our joined up healthcare and health research system, we have been able to get hundreds of patients involved in this clinical trial in just 2 weeks.
This marks a significant step in identifying treatments for coronavirus that could benefit patients and underpins our science-backed approach to fighting this virus.
With shortages of ventilation units and drugs to help in America and uk, once results are out, if they are successful trials then this will rocket, probably more than any share we have ever seen. If it doesn't work then its a long road with COPD or sell up and move on.
Thats the same drug trump said Americans are gonna use. Not looking good for them if this is there way out of this.
Id delete that if i could degs. Great find but she will unfortunately get too many followers from here and not post anything.
Maybe a new wife too on the side!
Hard work to get shares today, final top ups of 10k 9800 and 5k. Grand total of 130k shares. This will save lives snd hopefully pay off my mortgage.
Time to sit back, read the board here and enjoy the ride.
Gla.
For a company who was meant to have solid Covid-19 drug, its very quite on here. Something fishy or just bad news? Have a small share count here
If your premium then you see them all, otherwise you see about 100 or so of the most recent. Today there has been big buys, around 25k 50k 75k.big enough for someone to know something.
Someone knows something, we all know you buy shares with money you can afford to lose, but some msssive buys here suggests someone doesn't care about the current price, but getting in for the future price. Someone intends to make a lot of money here
Any idea of the running costs for each monitor per year? I think they have sold over 200 so far this year
Do they realy make the best? They have limited stock and suppliers are in Singapore so can't get much out of there right now.
Why the sudden drop 6 weeks ago. No RNS or bad news so I'm baffled. Read all the Rns but can't seem it find bad news....